University Medical Center, Paige partner to study clinical AI

Artificial intelligence company Paige has partnered with University Medical Center Utrecht (Netherlands) to study the clinical use of AI.

Through the partnership, UMC Utrecht will use Paige's suite of AI prostate health tools, and clinicians will report on the efficiency of diagnoses provided by these AI tools, according to a Nov. 16 Paige news release.

In addition to prostate cancer detection, UMC Utrecht will evaluate Paige's AI tool that aims to detect if breast cancer has metastasized to lymph nodes. 

"UMC Utrecht and Paige share a vision to improve outcomes for patients with cancer and health systems by leveraging quality AI solutions that help standardize the cancer diagnosis process," Paige CEO Andy Moye, PhD, said. "Specifically, this collaboration builds on pioneering work from Utrecht which demonstrated large systemic variability in Gleason scoring of prostate biopsies nationwide in the Netherlands. Paige's AI software can help overcome these diagnostic challenges. This partnership marks another significant milestone in our efforts to modernize and improve the process of cancer diagnosis globally."

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars